Rhumbline Advisers Has $710,000 Stock Holdings in Koninklijke Philips (NYSE:PHG)

Rhumbline Advisers raised its holdings in Koninklijke Philips (NYSE:PHGFree Report) by 5.3% in the 2nd quarter, according to the company in its most recent filing with the SEC. The firm owned 28,170 shares of the technology company’s stock after acquiring an additional 1,420 shares during the quarter. Rhumbline Advisers’ holdings in Koninklijke Philips were worth $710,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of PHG. Wealth Enhancement Advisory Services LLC lifted its stake in shares of Koninklijke Philips by 6.9% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 60,365 shares of the technology company’s stock worth $1,207,000 after acquiring an additional 3,891 shares during the period. Principal Securities Inc. acquired a new position in shares of Koninklijke Philips in the 4th quarter worth approximately $27,000. Corient Private Wealth LLC boosted its stake in shares of Koninklijke Philips by 21.0% in the 4th quarter. Corient Private Wealth LLC now owns 64,724 shares of the technology company’s stock valued at $1,510,000 after purchasing an additional 11,211 shares during the last quarter. Envestnet Portfolio Solutions Inc. increased its position in shares of Koninklijke Philips by 12.9% during the second quarter. Envestnet Portfolio Solutions Inc. now owns 26,515 shares of the technology company’s stock worth $668,000 after buying an additional 3,040 shares during the period. Finally, OLD Mission Capital LLC raised its stake in Koninklijke Philips by 434.9% during the fourth quarter. OLD Mission Capital LLC now owns 434,282 shares of the technology company’s stock worth $10,132,000 after buying an additional 353,096 shares during the last quarter. Institutional investors own 13.67% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Monday, July 15th. Three research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat, Koninklijke Philips currently has an average rating of “Hold”.

Check Out Our Latest Stock Report on Koninklijke Philips

Koninklijke Philips Price Performance

Shares of PHG opened at $30.80 on Wednesday. The firm has a market cap of $28.95 billion, a PE ratio of -32.08, a price-to-earnings-growth ratio of 1.06 and a beta of 0.73. Koninklijke Philips has a 52-week low of $17.75 and a 52-week high of $31.50. The business’s 50 day moving average price is $29.06 and its two-hundred day moving average price is $25.91. The company has a debt-to-equity ratio of 0.60, a quick ratio of 0.74 and a current ratio of 1.16.

Koninklijke Philips (NYSE:PHGGet Free Report) last released its quarterly earnings data on Monday, July 29th. The technology company reported $0.32 earnings per share for the quarter. The company had revenue of $4.80 billion during the quarter. Koninklijke Philips had a negative net margin of 2.35% and a positive return on equity of 10.15%. On average, equities analysts anticipate that Koninklijke Philips will post 1.51 EPS for the current year.

Koninklijke Philips Company Profile

(Free Report)

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.

See Also

Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips (NYSE:PHGFree Report).

Institutional Ownership by Quarter for Koninklijke Philips (NYSE:PHG)

Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.